ELEVANCE HEALTH, INC. (ELV) FY2025 Q1 Statement of Cash Flows

Statement of Cash Flows

2025-01-01 to 2025-03-31

Swipe to see the full flow
ELEVANCE HEALTH, INC. cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $1,017,000,000.00Net income → Operating adjustments reconciliation: $1,167,000,000.00Accounts payable and other liabilities → Operating adjustments reconciliation: $952,000,000.00Policy liabilities → Operating adjustments reconciliation: $600,000,000.00Net losses on financial instruments → Operating adjustments reconciliation: $464,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $373,000,000.00Income taxes → Operating adjustments reconciliation: $357,000,000.00Unearned income → Operating adjustments reconciliation: $132,000,000.00Share-based compensation → Operating adjustments reconciliation: $81,000,000.00Operating adjustments reconciliation → Receivables, net: $3,174,000,000.00Operating adjustments reconciliation → Other assets: $647,000,000.00Operating adjustments reconciliation → Deferred income taxes: $174,000,000.00Operating adjustments reconciliation → Equity in net (earnings) losses of other invested assets: $126,000,000.00Operating adjustments reconciliation → Other invested assets: $5,000,000.00Proceeds from sale of investments → investing reconciliation: $4,150,000,000.00Maturities, calls and redemptions from investments → investing reconciliation: $424,000,000.00Purchases of subsidiaries, net of cash acquired → investing reconciliation: $4,000,000.00investing reconciliation → Net cash from investing activities: $103,000,000.00investing reconciliation → Purchases of investments: $3,964,000,000.00investing reconciliation → Changes in securities lending collateral: $290,000,000.00investing reconciliation → Purchases of property and equipment: $196,000,000.00investing reconciliation → Other, net: $25,000,000.00Net cash used in financing activities → financing reconciliation: $1,909,000,000.00Changes in bank overdrafts → financing reconciliation: $546,000,000.00Changes in securities lending payable → financing reconciliation: $290,000,000.00Proceeds from issuance of common stock under employee stock plans → financing reconciliation: $23,000,000.00financing reconciliation → Repayments of long-term borrowings: $1,250,000,000.00financing reconciliation → Repurchase and retirement of common stock: $880,000,000.00financing reconciliation → Cash dividends: $386,000,000.00financing reconciliation → Taxes paid through withholding of common stock under employee stock plans: $123,000,000.00financing reconciliation → Repayments of short-term borrowings: $115,000,000.00financing reconciliation → Other, net: $14,000,000.00Exchange-rate effect → Cash sources and uses: $1,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $8,288,000,000.00Net cash from operating activities → Cash sources and uses: $1,017,000,000.00Net cash from investing activities → Cash sources and uses: $103,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $7,500,000,000.00Cash sources and uses → Net cash used in financing activities: $1,909,000,000.00Net income: $2,184,000,000.00Net income+$2.18 BAccounts payable and other liabilities: $952,000,000.00Payables & other liabilities+$952.00 MEquity in net (earnings) losses of other invested assets: -$126,000,000.00Equity-method results−$126.00 MShare-based compensation: $81,000,000.00Stock-based compensation+$81.00 MIncome taxes: $357,000,000.00Income taxes, net+$357.00 MPolicy liabilities: $600,000,000.00Insurance liabilities+$600.00 MDeferred income taxes: -$174,000,000.00Deferred income taxes−$174.00 MOther assets: -$647,000,000.00Other operating assets−$647.00 MNet losses on financial instruments: $464,000,000.00Net losses on financial instruments+$464.00 MDepreciation and amortization: $373,000,000.00D&A and accretion+$373.00 MReceivables, net: -$3,174,000,000.00Receivables, net−$3.17 BUnearned income: $132,000,000.00Unearned revenue+$132.00 MOther invested assets: -$5,000,000.00Trading securities, net−$5.00 MNet cash from operating activities: $1,017,000,000.00Operating cash+$1.02 BOperating adjustments reconciliation: $4,126,000,000.00Taxes paid through withholding of common stock under employee stock plans: -$123,000,000.00Stock-award tax withholding−$123.00 MProceeds from issuance of common stock under employee stock plans: $23,000,000.00Stock option exercises+$23.00 MCash dividends: -$386,000,000.00Dividends paid−$386.00 MRepayments of long-term borrowings: -$1,250,000,000.00Long-term debt repaid−$1.25 BOther, net: -$14,000,000.00Other financing, net−$14.00 MChanges in securities lending payable: $290,000,000.00Securities lending, net+$290.00 MRepurchase and retirement of common stock: -$880,000,000.00Common stock repurchases−$880.00 MChanges in bank overdrafts: $546,000,000.00Outstanding checks, net+$546.00 MProceeds from short-term borrowings: $0.00Repayments of short-term borrowings: -$115,000,000.00Short-term debt repaid−$115.00 MNet cash used in financing activities: -$1,909,000,000.00. Cash required to fund net payments.Financing cash−$1.91 Bfinancing reconciliation: $2,768,000,000.00Other, net: -$25,000,000.00Other investing, net−$25.00 MMaturities, calls and redemptions from investments: $424,000,000.00AFS securities maturities+$424.00 MProceeds from sale of investments: $4,150,000,000.00Proceeds from sale of investments+$4.15 BPurchases of property and equipment: -$196,000,000.00PP&E purchases−$196.00 MChanges in securities lending collateral: -$290,000,000.00Securities loan collateral, net−$290.00 MPurchases of investments: -$3,964,000,000.00Investment purchases−$3.96 BPurchases of subsidiaries, net of cash acquired: $4,000,000.00Acquisitions, net of cash+$4.00 MNet cash from investing activities: $103,000,000.00Investing cash+$103.00 Minvesting reconciliation: $4,578,000,000.00Cash sources and uses: $9,409,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $8,288,000,000.00Beginning cash$8.29 BEnding cash: Cash, cash equivalents, and restricted cash: $7,500,000,000.00Ending cash$7.50 BExchange-rate effect: $1,000,000.00FX effect+$1.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$821.00 MOperating cash − cash spent on PP&ECash flow / Net income0.47×Operating cash flow ÷ net incomeNet cash change−$788.00 MEnding cash − beginning cash
Chart details

ELEVANCE HEALTH, INC. cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025

Cash flows for Jan 1, 2025 through Mar 31, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2024. Ending cash: Mar 31, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2024
8,288,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
1,017,000,000 US dollars. Net cash provided.
Net income
2,184,000,000 US dollars
Accounts payable and other liabilities
952,000,000 US dollars
Equity in net (earnings) losses of other invested assets
negative 126,000,000 US dollars
Share-based compensation
81,000,000 US dollars
Income taxes
357,000,000 US dollars
Policy liabilities
600,000,000 US dollars
Deferred income taxes
negative 174,000,000 US dollars
Other assets
negative 647,000,000 US dollars
Net losses on financial instruments
464,000,000 US dollars
Depreciation and amortization
373,000,000 US dollars
Receivables, net
negative 3,174,000,000 US dollars
Unearned income
132,000,000 US dollars
Other invested assets
negative 5,000,000 US dollars
Investing activities
103,000,000 US dollars. Net cash provided.
Other, net
negative 25,000,000 US dollars
Maturities, calls and redemptions from investments
424,000,000 US dollars
Proceeds from sale of investments
4,150,000,000 US dollars
Purchases of property and equipment
negative 196,000,000 US dollars
Changes in securities lending collateral
negative 290,000,000 US dollars
Purchases of investments
negative 3,964,000,000 US dollars
Purchases of subsidiaries, net of cash acquired
4,000,000 US dollars
Financing activities
negative 1,909,000,000 US dollars. Net cash used.
Taxes paid through withholding of common stock under employee stock plans
negative 123,000,000 US dollars
Proceeds from issuance of common stock under employee stock plans
23,000,000 US dollars
Cash dividends
negative 386,000,000 US dollars
Repayments of long-term borrowings
negative 1,250,000,000 US dollars
Other, net
negative 14,000,000 US dollars
Changes in securities lending payable
290,000,000 US dollars
Repurchase and retirement of common stock
negative 880,000,000 US dollars
Changes in bank overdrafts
546,000,000 US dollars
Proceeds from short-term borrowings
0 US dollars
Repayments of short-term borrowings
negative 115,000,000 US dollars
Operating adjustment reconciliation
4,126,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
2,768,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
4,578,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
1,000,000 US dollars
Ending cash on Mar 31, 2025
7,500,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
9,409,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 788,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.47×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
1,017,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
196,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
821,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $1.02B of net income directly to operating cash and $1.17B to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 1,017,000,000 US dollars minus 196,000,000 US dollars equals 821,000,000 US dollars.
ELEVANCE HEALTH, INC. (ELV) FY2025 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!